BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3484677)

  • 1. In vitro effect of monoclonal anti-idiotype antibodies (anti-M104E) on MOPC 104E myeloma cells.
    Kodama K; Ghanta VK; Hiramoto RN; Stohrer RC; Kearney JF
    Cancer Res; 1986 Mar; 46(3):1250-4. PubMed ID: 3484677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.
    Kodama K; Ghanta VK; Hiramoto NS; Hiramoto RN
    J Biol Response Mod; 1989 Aug; 8(4):385-96. PubMed ID: 2754437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitro.
    Miura T; Ghanta VK; Hiramoto RN
    Cancer Invest; 1990; 8(1):17-25. PubMed ID: 2350718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of PFC inhibition assays to distinguish idiotypically between clonotypes that are readily distinguishable by RIA analysis.
    Schepart BS; Mayers GL; Bankert RB
    J Immunol; 1985 Sep; 135(3):1683-9. PubMed ID: 2410500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic and anti-idiotypic B-B cell interaction is controlled by major histocompatibility complex-restricted regulation.
    Bitoh S; Fujimoto S; Yamamoto H
    Immunology; 1989 Apr; 66(4):479-84. PubMed ID: 2469640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of helper T cells that recognize a cross-reactive idiotype through a network mechanism.
    Masaki H; Irimajiri K
    Microbiol Immunol; 1992; 36(3):279-95. PubMed ID: 1376394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.
    Hayashida I; Hiramoto RN; Shrestha K; Ghanta VK
    Cancer Invest; 1989; 7(1):17-26. PubMed ID: 2567619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus-independent induction of idiotype suppression in newborn mice by syngeneic anti-idiotype antisera.
    Lehle G; Weiler E
    Eur J Immunol; 1985 Jun; 15(6):580-6. PubMed ID: 2408898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isogeneic monoclonal antibodies against anti-alpha(1----3)dextran idiotypes. I. Isotypes, idiotope specificity and representation of idiotopes in antisera from mice of various genetic constitutions.
    Wilke J; Weiler E
    Eur J Immunol; 1987 Feb; 17(2):255-60. PubMed ID: 2435560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan.
    Barker E; Mokyr MB
    Cancer Immunol Immunother; 1987; 25(3):215-24. PubMed ID: 3677124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syngeneic monoclonal anti-idiotype antibody against HNK-1: characterization and cytotoxic activity in vitro.
    Schluep M; Page N; Burger D; Steck AJ
    Clin Exp Immunol; 1989 Feb; 75(2):301-5. PubMed ID: 2649290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
    Haimovich J; Kukulansky T; Weissman B; Hollander N
    Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
    Nio Y; Ohgaki K; Tobe T
    J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
    Weiner GJ; Kaminski MS
    J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal anti-idiotypic antibody against a human monoclonal IgM with specificity for myelin-associated glycoprotein.
    Page N; Murray N; Perruisseau G; Steck AJ
    J Immunol; 1985 May; 134(5):3094-9. PubMed ID: 2580012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the idiotypic network in tumor immunity.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies.
    Hirashima K; Zenita K; Takada A; Kitahara A; Ishihara G; Harada R; Ohmori K; Hirohashi S; Kyoizumi S; Akiyama M
    J Immunol; 1990 Jul; 145(1):224-32. PubMed ID: 1972718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.